Searched for
OLMESARTAN MEDOXOMIL TABLETS
Will the currency cycle help them? Yes, but very selectively: 10 pharma stocks with upside potential of up to 33%- Fresh tailwinds emerge as government comes in again with intent: 7 pharma stocks with upside potential of up to 36%
- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…
- One simple reason to own & trade them: 5 large-caps from different sectors with upside potential of up to 46%The rising stock price of a company does not mean that the business is strong. And a falling stock price does not mean that the business is...03 Jul, 2025, 12.48 PM IST
- Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has annou...03 Apr, 2025, 06.56 PM IST
- Pharma: Stay bullish, but hedge to avoid mistake of selling due to deadline. 7 stocks with upside potential of up to 50%While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about keeping the co...22 Mar, 2025, 06.29 PM IST
- Look for good quality businesses at relatively lower valuations: 5 large-caps from different sectors with upside potential of up to 44%Our headline says “relatively” lower valuations. Now, “relatively” is used in two contexts. A stock that was trading at a PE of 93 is today...27 Feb, 2025, 08.46 PM IST
- Decline in rupee: Besides IT, there are other winners as well; 9 pharma stocks with an upside potential of up to 40%The relationship between a decline in the rupee and better margins for IT companies is well known. What is not discussed much is that pharm...14 Jan, 2025, 02.13 PM IST
- Paracetamol to PAN-D: CDSCO finds over 50 sub-standard drugs. Check full list of medicinesThe Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The...06 Nov, 2024, 12.45 PM IST
- Macleods Pharmaceuticals recalls products in US for manufacturing issuesThe company had produced the affected lot at its Baddi plant and later marketed in the US market by Macleods Pharma USA Inc.13 Mar, 2022, 11.08 AM IST
- need2know: Nine macro triggers that should matter for market todayThe United Nations Security Council is mulling tough new sanctions against North Korea05 Sep, 2017, 07.54 AM IST
- Lupin launches generic hypertension drug in US marketThe Mumbai-based company's product is the generic equivalent of Daiichi Sankyo Inc's Benicar tablets which is indicated for the treatment o...04 Sep, 2017, 01.44 PM IST
- Glenmark gets US FDA nod for high blood pressure medicineGlenmark’s current portfolio consists of 119 products authorized for distribution in the US and 66 Abbreviated New Drug Approvals (ANDAs) p...07 Jul, 2017, 10.16 AM IST
- Jubilant gets USFDA nod for generic hypertension drugThe company's product is a generic version of Daiichi Sankyo's Azor which is used for the treatment of hypertension.17 May, 2017, 02.01 PM IST
- Stock pick of the week: What makes Alembic Pharma a good bet in muted pharma industryInvestment in R&D and new facilities focus on exports, new launches and likely growth in revenue of about 35% in the coming years has made ...01 May, 2017, 06.30 AM IST
- ETMarkets After Hours: RIL among 150 stocks @52-wk high; Axis Bank rallies 3%All the sectoral indices closed in the green on BSE on Tuesday with the BSE Telecom index gaining 2.62 per cent.25 Apr, 2017, 03.59 PM IST
- Jubilant Life gets USFDA nod for hypertension drugIn a BSE filing, the company said it has received abbreviated new drug application (ANDA) final approval for olmesartan medoxomil tablets -...25 Apr, 2017, 12.50 PM IST
- Alembic Pharma gets USFDA nod for anti-hypertension drugsThe approved products are therapeutically equivalent to the reference listed drug products Benicar and Benicar HCT of Daiichi Sankyo, which...25 Apr, 2017, 12.47 PM IST
- Ajanta Pharma launches BP lowering tablets in USAjanta Pharma's Amlodipine + Olmesartan Medoxomil tablets are a generic version of Daiichi Sankyo Inc's Azor tablets02 Nov, 2016, 06.05 PM IST
- Global pharma cos to reduce pill prices in IndiaGlobal pharmaceutical companies are launching their medicines in India at up to one-fifth of their global prices. World News and Trends06 Jun, 2008, 04.54 AM IST
Load More
